Corticosteroids for non-severe COVID-19 infections? Too early to conclude

참고문헌 (11)

1. RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with COVID-19", N Engl J Med, 384, pp.693~704 (2021)
2. Emad R. Issak, "Timing of corticosteroids in non-severe non-hospitalized COVID-19 patients: open-label, two-center, randomized controlled study (TICS-COV19 study)", The Korean Journal of Internal Medicine, 38(2), pp.207~217 (2023), 대한내과학회[DOI]
3. Li Q, "Efficacy evaluation of early, low-dose, short-term corticosteroids in adults hospitalized with non-severe COVID-19 pneumonia : a retrospective cohort study", Infect Dis Ther, 9, pp.823~836 (2020)
4. Yuan M, "Effects of corticosteroid treatment for non-severe COVID-19 pneumonia : a propensity scorebased analysis", Shock, 54, pp.638~643 (2020)
5. Almas T, "Safety and efficacy of low-dose corticosteroids in patients with non-severe coronavirus disease 2019 : a retrospective cohort study", Cureus, 13, pp.e12544~ (2021)
6. "Therapeutics and COVID-19:Living guideline" (2023)[URL]
7. Alhazzani W, "Surviving sepsis campaign guidelines on the management of adults with coronavirus disease 2019(COVID-19)in the ICU : first update", Crit Care Med, 49, pp.e219~e234 (2021)
8. Wagner C, "Systemic corticosteroids for the treatment of COVID-19 : equity-related analyses and update on evidence", Cochrane Database Syst Rev, 11, pp.CD014963~ (2022)
9. "COVID-19 treatment guidelines"[URL]
10. Yu LM, "Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK(PRINCIPLE) : a randomised, controlled, open-label, adaptive platform trial", Lancet, 398, pp.843~855 (2021)
11. Clemency BM, "Efficacy of inhaled ciclesonide for outpatient treatment of adolescents and adults with symptomatic COVID-19 : a randomized clinical trial", JAMA Intern Med, 182, pp.42~49 (2022)

관련 논문AI추천